CRY’s research program is changing the way we understand, diagnose and manage conditions that can cause young sudden cardiac death (YSCD)
In the UK CRY are best know for raising awareness of young sudden cardiac death, for the support we offer to families after a tragedy, and for the cardiac screening services we offer to all young people. Throughout the rest of the world we are better known for the research we are publishing which is having a direct and immediate impact on clinical practice.
25p in every pound CRY spends goes towards research.
CRY’s research is vital in helping us to better understand the prevalence and causes of Young Sudden Cardiac Death, as well as improve our ability to diagnose and manage cardiac conditions in young people.
Clinical data obtained through the CRY screening programme, at the CRY Centre for Inherited Cardiovascular Disease and Sports Cardiology and the CRY Centre for Cardiac Pathology is analysed and reported by CRY’s Research team in peer review journals to influence policy and practice in the UK and internationally.
CRY’s research is focused on learning from what we do in clinic today to improve the way people at risk are treated tomorrow.
A list, with links of all of CRY’s research can be found here.
The data derived from the CRY screening program has dramatically improved our understanding of electrocardiogram (ECG) patterns commonly present in young individuals and how these can vary for individuals of different ethnic backgrounds, genders, ages, sizes, levels of athletic activity and sporting disciplines.
Establishing what constitutes a normal pattern is crucial in order to accurately differentiate between traits attributed to the individual’s demographics and characteristics that may represent underlying cardiac pathology and should trigger further clinical evaluation. By devising clear, demographic-specific criteria CRY have reduced the false positive rate of the 12-lead ECG and utilise it as a useful screening tool in the context of a diverse, young population in the UK.